Pinnacle Wealth Management Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.29M | Buy |
17,031
+964
| +6% | +$207K | 0.26% | 84 |
|
|
2026
Q1 | $3.49M | Sell |
16,067
-423
| -3% | -$93.8K | 0.24% | 88 |
|
|
2025
Q4 | $3.77M | Buy |
16,490
+90
| +0.5% | +$20.5K | 0.26% | 81 |
|
|
2025
Q3 | $3.8M | Sell |
16,400
-85
| -0.5% | -$17.3K | 0.29% | 76 |
|
|
2025
Q2 | $3.06M | Buy |
16,485
+1,127
| +7% | +$209K | 0.25% | 79 |
|
|
2025
Q1 | $3.22M | Buy |
15,358
+111
| +0.7% | +$21.6K | 0.3% | 74 |
|
|
2024
Q4 | $2.71M | Buy |
15,247
+3,947
| +35% | +$726K | 0.25% | 79 |
|
|
2024
Q3 | $2.23M | Buy |
11,300
+173
| +2% | +$32.3K | 0.21% | 89 |
|
|
2024
Q2 | $1.91M | Sell |
11,127
-125
| -1% | -$20.7K | 0.2% | 93 |
|
|
2024
Q1 | $2.05M | Sell |
11,252
-574
| -5% | -$98.9K | 0.22% | 89 |
|
|
2023
Q4 | $1.83M | Sell |
11,826
-888
| -7% | -$129K | 0.21% | 88 |
|
|
2023
Q3 | $1.9M | Buy |
12,714
+458
| +4% | +$67.2K | 0.25% | 85 |
|
|
2023
Q2 | $1.65M | Sell |
12,256
-248
| -2% | -$36.4K | 0.21% | 92 |
|
|
2023
Q1 | $1.99M | Sell |
12,504
-1,442
| -10% | -$220K | 0.27% | 80 |
|
|
2022
Q4 | $2.25M | Sell |
13,946
-660
| -5% | -$101K | 0.34% | 65 |
|
|
2022
Q3 | $1.96M | Buy |
14,606
+2,206
| +18% | +$317K | 0.33% | 72 |
|
|
2022
Q2 | $1.9M | Buy |
12,400
+176
| +1% | +$26.9K | 0.31% | 78 |
|
|
2022
Q1 | $1.98M | Buy |
12,224
+1,245
| +11% | +$181K | 0.29% | 83 |
|
|
2021
Q4 | $1.49M | Buy |
10,979
+2,581
| +31% | +$305K | 0.24% | 93 |
|
|
2021
Q3 | $906K | Sell |
8,398
-398
| -5% | -$45.5K | 0.21% | 104 |
|
|
2021
Q2 | $991K | Buy |
8,796
+2,000
| +29% | +$225K | 0.23% | 97 |
|
|
2021
Q1 | $735K | Sell |
6,796
-40
| -0.6% | -$4.28K | 0.21% | 98 |
|
|
2020
Q4 | $733K | Buy |
6,836
+1,182
| +21% | +$114K | 0.22% | 94 |
|
|
2020
Q3 | $495K | Buy |
5,654
+785
| +16% | +$73.9K | 0.17% | 110 |
|
|
2020
Q2 | $478K | Buy |
4,869
+1,720
| +55% | +$151K | 0.18% | 111 |
|
|
2020
Q1 | $240K | Buy |
3,149
+885
| +39% | +$75.4K | 0.12% | 136 |
|
|
2019
Q4 | $200K | Buy |
+2,264
| New | +$188K | 0.07% | 183 |
|
|
2019
Q2 | – | Sell |
-11,747
| Closed | -$947K | – | 185 |
|
|
2019
Q1 | $947K | Sell |
11,747
-584
| -5% | -$47.8K | 0.43% | 73 |
|
|
2018
Q4 | $1.14M | Buy |
12,331
+206
| +2% | +$18.1K | 0.62% | 47 |
|
|
2018
Q3 | $1.15M | Buy |
12,125
+566
| +5% | +$53.7K | 0.57% | 55 |
|
|
2018
Q2 | $1.07M | Buy |
11,559
+361
| +3% | +$35.3K | 0.58% | 54 |
|
|
2018
Q1 | $1.06M | Sell |
11,198
-150
| -1% | -$16.5K | 0.6% | 51 |
|
|
2017
Q4 | $1.1M | Buy |
11,348
+61
| +0.5% | +$5.75K | 0.61% | 51 |
|
|
2017
Q3 | $1M | Buy |
11,287
+160
| +1% | +$12.2K | 0.58% | 58 |
|
|
2017
Q2 | $807K | Buy |
11,127
+1,116
| +11% | +$75K | 0.5% | 67 |
|
|
2017
Q1 | $652K | Buy |
10,011
+286
| +3% | +$18K | 0.45% | 70 |
|
|
2016
Q4 | $609K | Buy |
9,725
+450
| +5% | +$27.5K | 0.44% | 67 |
|
|
2016
Q3 | $585K | Buy |
9,275
+50
| +0.5% | +$3.24K | 0.44% | 67 |
|
|
2016
Q2 | $571K | Buy |
9,225
+4,885
| +113% | +$298K | 0.45% | 65 |
|
|
2016
Q1 | $248K | Hold |
4,340
| – | – | 0.22% | 94 |
|
|
2015
Q4 | $257K | Sell |
4,340
-150
| -3% | -$8.64K | 0.23% | 88 |
|
|
2015
Q3 | $244K | Buy |
4,490
+64
| +1% | +$4.17K | 0.24% | 82 |
|
|
2015
Q2 | $297K | Buy |
4,426
+1
| +0% | +$65 | 0.27% | 83 |
|
|
2015
Q1 | $259K | Hold |
4,425
| – | – | 0.23% | 91 |
|
|
2014
Q4 | $290K | Buy |
+4,425
| New | +$279K | 0.27% | 83 |
|
Other funds holding ABBV
Pinnacle Wealth Management Advisory Group's ABBV Position: Q2 2026 in Review
Pinnacle Wealth Management Advisory Group increased its AbbVie (ABBV) stake by 6% in Q2 2026, buying an estimated $207K and bringing the position to 17,031 shares worth $4.29M. The position accounts for 0.26% of the portfolio, ranked #84.
Pinnacle Wealth Management Advisory Group first reported a position in ABBV in Q4 2014 and has held it in 45 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Pinnacle Wealth Management Advisory Group held 17,031 shares of AbbVie worth $4.29M as of Q2 2026.
- Pinnacle Wealth Management Advisory Group bought 964 AbbVie shares in Q2 2026, an estimated $207K.
- AbbVie made up 0.26% of Pinnacle Wealth Management Advisory Group's portfolio in Q2 2026, its #84 holding.
- Pinnacle Wealth Management Advisory Group first reported a position in AbbVie in Q4 2014 and has held it in 45 quarters since.
- 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Pinnacle Wealth Management Advisory Group's 13F filing for Q2 2026, filed 5 Aug 2026.